Gestational diabetes
From W8MD weight loss and sleep centers
Gestational diabetes is diabetes first recognized during pregnancy, usually caused by pregnancy-related insulin resistance in a person with limited insulin reserve
| Gestational diabetes | |
|---|---|
| Synonyms | N/A |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Often asymptomatic; may include increased thirst, frequent urination, fatigue, recurrent infections, excessive fetal growth, or abnormal glucose screening |
| Complications | Macrosomia, preeclampsia, cesarean delivery, neonatal hypoglycemia, shoulder dystocia, preterm birth, future type 2 diabetes, future metabolic syndrome |
| Onset | N/A |
| Duration | N/A |
| Types | N/A |
| Causes | Pregnancy-related insulin resistance, placental hormones, underlying subclinical insulin resistance, obesity, family history, PCOS, prior gestational diabetes, excess gestational weight gain |
| Risks | N/A |
| Diagnosis | Glucose screening, oral glucose tolerance test, fasting glucose, early diabetes screening in high-risk patients, postpartum glucose testing |
| Differential diagnosis | N/A |
| Prevention | N/A |
| Treatment | Medical nutrition therapy, glucose monitoring, physical activity, insulin when needed, metformin or glyburide in selected cases, postpartum diabetes prevention, long-term weight management |
| Medication | N/A |
| Prognosis | N/A |
| Frequency | N/A |
| Deaths | N/A |
Gestational diabetes is a type of diabetes first recognized during pregnancy. It occurs when the body cannot produce enough insulin to overcome the natural insulin resistance of pregnancy. Insulin is a hormone made by the pancreas that helps move glucose from the bloodstream into cells. During pregnancy, placental hormones make the mother's body more insulin resistant so that more glucose is available for fetal growth. Most pregnant people can compensate by producing more insulin. Gestational diabetes develops when pancreatic insulin production cannot keep up with this increased demand.
The central metabolic issue in gestational diabetes is insulin resistance. Pregnancy normally creates a state of progressive insulin resistance, especially in the second and third trimesters. For patients with underlying subclinical insulin resistance before pregnancy, pregnancy can act like a metabolic stress test. If a person already has insulin resistance due to genetic risk, obesity, abdominal weight gain, PCOS, prior gestational diabetes, family history of type 2 diabetes, poor sleep, or metabolic syndrome, pregnancy may reveal the condition as gestational diabetes.
W8MD Weight Loss, Sleep and MedSpa physicians have over 16 years of experience helping patients with insulin resistance, obesity, prediabetes, type 2 diabetes risk, PCOS-related weight gain, metabolic syndrome, sleep apnea, postpartum weight management, and long-term diabetes prevention. While active gestational diabetes during pregnancy should be managed by obstetrics, maternal-fetal medicine, endocrinology, or diabetes specialists, W8MD can help before pregnancy, between pregnancies, and after pregnancy with evidence-based medical weight management, low-glycemic nutrition, culturally customized diet plans, GLP-1 medications when appropriate after pregnancy and breastfeeding, traditional weight-loss medications when appropriate, meal replacements, sleep apnea evaluation, and long-term prevention of type 2 diabetes.
Overview
Gestational diabetes is usually diagnosed during pregnancy, most often between 24 and 28 weeks of gestation, although high-risk patients may need earlier screening for undiagnosed type 2 diabetes or early abnormal glucose metabolism.Diabetes During Pregnancy(link). Centers for Disease Control and Prevention.May 15, 2024."15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2026".Diabetes Care.2026;49(Supplement_1)
- S321-S335.doi:10.2337/dc26-S015.
Gestational diabetes matters because it affects both the pregnant person and the baby. With proper diagnosis and management, many patients have healthy pregnancies and healthy babies. Without adequate treatment, gestational diabetes can increase the risk of maternal and neonatal complications.
Gestational diabetes is associated with increased risk of:
- Macrosomia
- Large-for-gestational-age infant
- Preeclampsia
- Cesarean delivery
- Shoulder dystocia
- Birth trauma
- Neonatal hypoglycemia
- Neonatal jaundice
- Preterm birth
- Future maternal type 2 diabetes
- Future offspring obesity and glucose intolerance
Insulin resistance as the underlying issue
Insulin resistance is the key metabolic driver of gestational diabetes. During pregnancy, the placenta produces hormones and inflammatory signals that make insulin less effective. This is a normal part of pregnancy, but it becomes a problem when the pancreas cannot produce enough additional insulin to keep blood glucose normal.
The CDC explains that all pregnant women have some insulin resistance during late pregnancy, but some women have insulin resistance even before pregnancy, begin pregnancy with a higher need for insulin, and are more likely to develop gestational diabetes.Gestational Diabetes(link). Centers for Disease Control and Prevention.May 15, 2024.
The NIDDK similarly explains that pregnancy hormones and weight gain can make the body's cells less able to use insulin, and that some pregnant people cannot produce enough insulin to overcome this resistance.Symptoms & Causes of Gestational Diabetes(link). National Institute of Diabetes and Digestive and Kidney Diseases.
Pregnancy as a metabolic stress test
Pregnancy can be understood as a metabolic stress test for insulin resistance. Before pregnancy, a patient may have normal fasting glucose and a normal HbA1c because the pancreas is producing extra insulin to compensate for underlying insulin resistance. During pregnancy, insulin resistance rises sharply, especially in the second and third trimesters. If the pancreas cannot increase insulin output enough, blood glucose rises and gestational diabetes appears.
This helps explain why gestational diabetes is more common in patients with:
- Obesity
- Abdominal weight gain
- Family history of type 2 diabetes
- Prior gestational diabetes
- PCOS
- Prediabetes
- Metabolic syndrome
- History of large baby
- Sleep apnea
- Sedentary lifestyle
- High-glycemic diet
- Certain racial and ethnic risk backgrounds
The American Diabetes Association Standards of Care in Diabetes—2026 states that pregnancy is characterized by progressive insulin resistance in the second and third trimesters due to diabetogenic placental factors."15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2026".Diabetes Care.2026;49(Supplement_1)
- S321-S335.doi:10.2337/dc26-S015.
Gestational diabetes is not just a pregnancy problem
Gestational diabetes often resolves after delivery because the placenta is delivered and pregnancy-related insulin resistance falls. However, it should not be dismissed as a temporary issue only. Gestational diabetes is a strong warning sign of future insulin resistance, prediabetes, and type 2 diabetes risk.
The ADA Standards of Care in Diabetes—2026 recommends postpartum screening for diabetes or prediabetes at 4-12 weeks postpartum with a 75-g oral glucose tolerance test, and lifelong screening every 1-3 years thereafter depending on risk."15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2026".Diabetes Care.2026;49(Supplement_1)
- S321-S335.doi:10.2337/dc26-S015.
Causes and risk factors
Gestational diabetes develops from the interaction of pregnancy-related insulin resistance and the body's ability to produce enough insulin.
Risk factors include:
- Prior gestational diabetes
- Prediabetes before pregnancy
- Overweight or obesity
- Abdominal obesity
- PCOS
- Family history of type 2 diabetes
- Prior large baby
- Older maternal age
- Sedentary lifestyle
- High-glycemic dietary pattern
- Excess gestational weight gain
- Sleep apnea
- Chronic hypertension
- Certain medications
- History of metabolic syndrome
Symptoms
Gestational diabetes often has no symptoms and is usually found by screening. When symptoms occur, they may be mild or nonspecific.
Possible symptoms include:
- Increased thirst
- Frequent urination
- Fatigue
- Blurred vision
- Recurrent yeast infections
- Unusual hunger
- Excessive fetal growth on ultrasound
- Abnormal glucose screening test
Diagnosis
Gestational diabetes is diagnosed using blood glucose testing. Different organizations and countries may use different screening methods, but common approaches include a one-step or two-step oral glucose testing strategy.
| Test | Description | Use |
|---|---|---|
| Early pregnancy diabetes screening | Fasting glucose, HbA1c, or other diabetes testing in high-risk patients | Identifies undiagnosed preexisting diabetes or early abnormal glucose metabolism |
| 50-g glucose challenge test | Nonfasting screening test followed by diagnostic testing if abnormal | Common first step in the two-step approach |
| 100-g oral glucose tolerance test | Fasting diagnostic test with multiple glucose measurements | Used after abnormal screening in the two-step approach |
| 75-g oral glucose tolerance test | Fasting test with glucose measurements after glucose drink | Used in one-step diagnosis and postpartum testing |
| Postpartum 75-g oral glucose tolerance test | Testing 4-12 weeks after delivery | Detects persistent diabetes or prediabetes after gestational diabetes |
ACOG Practice Bulletin No. 190 supports screening for gestational diabetes and notes that early pregnancy screening for undiagnosed type 2 diabetes is suggested in overweight and obese women with additional diabetes risk factors, including prior history of gestational diabetes."ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus".Obstetrics & Gynecology.2018;PMID:29370047.
Blood sugar goals
Blood sugar goals during pregnancy should be set by the treating obstetric, maternal-fetal medicine, endocrinology, or diabetes care team. Typical targets often include fasting and post-meal glucose goals, but individual goals may vary based on clinical situation.
Common monitoring times include:
- Fasting glucose
- 1-hour after meals
- 2-hour after meals
- Bedtime glucose when indicated
- Overnight glucose when indicated
Treatment
Treatment of gestational diabetes focuses on keeping blood sugar in a safe range for the mother and baby.
Treatment may include:
- Medical nutrition therapy
- Carbohydrate distribution
- Low-glycemic meal planning
- Blood glucose monitoring
- Physical activity when approved by obstetrics
- Gestational weight-gain counseling
- Insulin when needed
- Metformin or glyburide in selected cases
- Fetal growth monitoring when indicated
- Delivery planning
- Postpartum diabetes screening
- Long-term diabetes prevention
The CDC recommends that people with diabetes during pregnancy see their doctor as recommended, monitor blood sugar, follow a healthy eating plan developed with their doctor or dietitian, be physically active, and take insulin if directed.Diabetes During Pregnancy(link). Centers for Disease Control and Prevention.May 15, 2024.
Medical nutrition therapy
Nutrition is the foundation of gestational diabetes treatment. The goal is not starvation, crash dieting, or extreme carbohydrate avoidance. The goal is adequate pregnancy nutrition with controlled carbohydrate quality, spacing, and portions.
Medical nutrition therapy may include:
- Consistent carbohydrate intake
- Low-glycemic carbohydrates
- Protein with each meal
- Non-starchy vegetables
- Healthy fats
- Avoidance of sugar-sweetened beverages
- Avoidance of large refined carbohydrate loads
- Balanced snacks if needed
- Breakfast carbohydrate control
- Monitoring response to specific foods
- Cultural meal adaptation
Foods that often raise glucose
Foods that may raise blood glucose quickly include:
- Sugary drinks
- Fruit juice
- Candy
- Desserts
- Sweet cereals
- White bread
- White rice
- Large portions of pasta
- Potatoes in large portions
- Pastries
- Sweetened yogurt
- High-sugar coffee drinks
Foods often better tolerated
Foods often better tolerated in gestational diabetes meal planning include:
- Eggs
- Fish low in mercury
- Chicken
- Turkey
- Lean meats
- Tofu
- Greek yogurt without added sugar
- Beans or lentils in measured portions if tolerated
- Non-starchy vegetables
- Leafy greens
- Broccoli
- Cauliflower
- Zucchini
- Avocado
- Nuts and seeds in pregnancy-safe portions
- Olive oil
Pregnancy nutrition must also account for fetal development, micronutrients, nausea, reflux, constipation, food aversions, cultural preferences, and obstetric guidance.
Physical activity
Physical activity can improve insulin sensitivity and post-meal glucose in many pregnant patients, when approved by the obstetric clinician.
Examples may include:
- Walking after meals
- Prenatal exercise
- Light resistance activity
- Swimming
- Stationary cycling
- Gentle movement breaks
- Reduced prolonged sitting
Activity plans should be individualized and cleared by the pregnancy care team, especially in high-risk pregnancies.
Medication treatment during pregnancy
If nutrition therapy and physical activity do not control blood glucose, medication may be needed. Insulin is commonly used because it does not cross the placenta in clinically significant amounts and can be carefully adjusted. Metformin or glyburide may be used in selected circumstances depending on clinician judgment, patient factors, and local practice.
Medication decisions during pregnancy should be managed by obstetrics, maternal-fetal medicine, endocrinology, or diabetes specialists.
GLP-1 medication warning during pregnancy
GLP-1 weight loss injections such as Semaglutide, Tirzepatide, and Liraglutide are not used to treat gestational diabetes during pregnancy. Prescription weight-loss medications are generally avoided during pregnancy and breastfeeding unless a qualified clinician gives specific guidance.
Patients who are pregnant, trying to conceive, or breastfeeding should discuss any weight-loss medication, GLP-1 medication, diabetes medication, supplement, or diet plan with their pregnancy care team.
Complications for the mother
Gestational diabetes may increase maternal risk of:
- Preeclampsia
- High blood pressure
- Cesarean delivery
- Birth complications
- Future gestational diabetes
- Future prediabetes
- Future type 2 diabetes
- Metabolic syndrome
- Cardiovascular disease risk
Complications for the baby
Gestational diabetes may increase infant risk of:
- Large-for-gestational-age birth weight
- Macrosomia
- Shoulder dystocia
- Birth injury
- Neonatal hypoglycemia
- Respiratory distress
- Jaundice
- Preterm birth
- Later obesity risk
- Later glucose intolerance risk
Postpartum care
Postpartum care is critical because gestational diabetes identifies a person at increased future risk of type 2 diabetes. Blood glucose may normalize after delivery, but insulin resistance risk often remains.
Postpartum steps include:
- 75-g oral glucose tolerance test at 4-12 weeks postpartum
- Lifelong diabetes screening every 1-3 years
- Postpartum weight management
- Breastfeeding support when possible
- Healthy sleep planning
- Low-glycemic nutrition
- Physical activity after medical clearance
- Treatment of sleep apnea if present
- Planning before future pregnancies
- Diabetes prevention counseling
Gestational diabetes and future pregnancy planning
Patients with prior gestational diabetes should ideally enter future pregnancies with improved insulin sensitivity and metabolic health.
Preconception goals may include:
- Healthy weight loss before pregnancy if needed
- Improved glucose and HbA1c
- Low-glycemic nutrition
- Physical activity
- Sleep apnea diagnosis and treatment
- PCOS management
- Medication review before conception
- Early obstetric screening in future pregnancy
Gestational diabetes, PCOS, and insulin resistance
PCOS is closely linked to insulin resistance and increases the risk of gestational diabetes. Patients with PCOS may enter pregnancy with higher insulin levels and increased metabolic vulnerability.
A 2025 review reported that insulin resistance is highly prevalent in women and adolescents with PCOS, with estimates ranging from 35% to 80%, and noted that PCOS is associated with increased diabetes risk."Insulin resistance, metabolic syndrome and polycystic ovaries".Frontiers in Endocrinology.2025;PMC:12520869.
Gestational diabetes and sleep apnea
Sleep apnea is common in obesity and pregnancy and may worsen insulin resistance, blood pressure, fatigue, and glucose control. Patients with loud snoring, witnessed apneas, morning headaches, severe daytime sleepiness, or resistant hypertension should discuss sleep evaluation with their clinician.
W8MD can help nonpregnant and postpartum patients with:
- Sleep apnea screening
- Snoring evaluation
- Home sleep testing when appropriate
- CPAP/APAP support
- Weight and sleep counseling
How W8MD can help
W8MD Weight Loss, Sleep and MedSpa helps patients with insulin resistance and gestational diabetes risk before pregnancy, between pregnancies, and after pregnancy. W8MD is not a replacement for obstetric or maternal-fetal medicine care during active pregnancy, but it can play an important role in long-term metabolic prevention.
W8MD physicians have over 16 years of experience helping patients with insulin resistance, obesity, prediabetes, PCOS, metabolic syndrome, sleep apnea, gestational diabetes history, and weight management.
W8MD can help with:
- Insulin resistance risk assessment
- Postpartum weight management
- Prediabetes prevention
- Type 2 diabetes risk reduction
- PCOS-related weight management
- Metabolic syndrome care
- Nutrition counseling
- Low-glycemic diet
- Low-carbohydrate diet
- W8MD weight loss diet
- Culturally customized meal planning
- Meal replacements after pregnancy and breastfeeding when appropriate
- Exercise counseling
- Sleep apnea screening
- Home sleep test
- CPAP support
- Metformin discussion when appropriate
- GLP-1 weight loss injections after pregnancy and breastfeeding when appropriate
- Semaglutide after pregnancy and breastfeeding when appropriate
- Tirzepatide after pregnancy and breastfeeding when appropriate
- Traditional prescription diet pills after pregnancy and breastfeeding when appropriate
- Long-term weight loss maintenance
W8MD's clinical approach
| Patient situation | Why it matters | W8MD approach |
|---|---|---|
| Prior gestational diabetes | Strong warning sign for future type 2 diabetes risk | Postpartum weight management, low-glycemic nutrition, diabetes prevention |
| PCOS before pregnancy | PCOS is commonly linked to insulin resistance and GDM risk | Medical weight management, lower-glycemic plan, medication discussion when appropriate |
| Prediabetes before pregnancy | Higher risk of gestational diabetes and future type 2 diabetes | Preconception metabolic optimization and postpartum prevention support |
| Weight gain after pregnancy | Postpartum weight retention increases future metabolic risk | Nutrition counseling, meal replacements when appropriate, activity planning |
| Sleep apnea symptoms | Sleep apnea worsens insulin resistance and hypertension risk | Sleep evaluation, home sleep testing, CPAP/APAP support when appropriate |
| Cultural food preferences | Diet plans fail if they do not match real family meals | Customized low-glycemic meal plans by culture and cuisine |
| Need for long-term prevention | GDM risk continues after delivery | Ongoing medical weight management and metabolic follow-up |
Culturally customized gestational diabetes and insulin-resistance meal planning
A gestational diabetes or postpartum insulin-resistance diet must fit the patient's culture, budget, family meals, religious practices, and food preferences. W8MD can help patients after pregnancy and breastfeeding adapt low-glycemic and lower-carbohydrate principles to many cuisines.
| Food tradition | Higher-glycemic foods to reduce | Lower-glycemic substitutions |
|---|---|---|
| South Asian | White rice, naan, roti, dosa, idli, sweets | Tandoori chicken, paneer, eggs, fish curry, cauliflower rice, cucumber raita without sugar, sautéed greens |
| Mexican | Tortillas, rice, chips, sweet drinks | Fajita bowls without rice, grilled meats, avocado, salsa, lettuce wraps, cauliflower rice |
| Caribbean | Rice and peas, plantains, roti, dumplings, sweet drinks | Jerk chicken, fish, cabbage, callaloo, avocado, cauliflower rice |
| Mediterranean | Pita, rice, pasta, sweet desserts | Fish, Greek salad, olives, olive oil, grilled vegetables, chicken, lamb, yogurt sauces without sugar |
| Middle Eastern | Pita, rice, couscous, baklava | Kebabs, grilled fish, baba ganoush, cucumber salad, tahini, cauliflower tabbouleh |
| East Asian | White rice, noodles, dumplings, sweet sauces | Stir-fried protein with non-starchy vegetables, tofu, mushrooms, cabbage, cauliflower rice |
| American | Bread, fries, pasta, cereal, soda | Eggs, salads, grilled protein, bunless burgers, roasted non-starchy vegetables, low-carb meal replacements |
Sample postpartum insulin-resistance meal plan
This sample is educational and should be individualized. Pregnant and breastfeeding patients should follow their obstetric or dietitian-approved nutrition plan.
| Meal | Example |
|---|---|
| Breakfast | Eggs with spinach and avocado, or Greek yogurt without added sugar with chia seeds and berries |
| Lunch | Grilled chicken, fish, tofu, or paneer over salad with olive-oil dressing and non-starchy vegetables |
| Snack | Boiled egg, small portion of nuts, cheese stick, protein shake, or W8MD-style meal replacement when appropriate |
| Dinner | Salmon, chicken, turkey, tofu, or lean protein with broccoli, cauliflower rice, zucchini, or cabbage |
| Hydration | Water, unsweetened tea, black coffee, or electrolyte-aware fluids when appropriate |
Affordable W8MD medical weight-management options after pregnancy
W8MD help after gestational diabetes
W8MD offers physician-supervised options for eligible patients after pregnancy and breastfeeding who have insulin resistance, postpartum weight retention, prediabetes risk, PCOS, metabolic syndrome, or prior gestational diabetes.
- Semaglutide starting as low as $29.99/week and up with insurance for qualifying medical visits when medically appropriate.
- Tirzepatide starting as low as $45.00/week and up with insurance for qualifying medical visits when medically appropriate.
- Self-pay GLP-1 options may start from $59.99/week and up when available and medically appropriate.
- Traditional prescription diet pills may be available for eligible nonpregnant, non-breastfeeding patients when clinically appropriate.
- Nutrition counseling, meal replacements, sleep apnea care, and long-term follow-up may help improve insulin resistance and reduce future diabetes risk.
- Pricing, eligibility, medication access, dosing, insurance coverage, prior authorization, pharmacy availability, telemedicine availability, and program details vary by patient, medication, location, and medical evaluation.
W8MD patient success highlight
W8MD has helped thousands of patients since 2011. Individual results vary, but W8MD success stories include patients who lost more than 100 pounds and maintained long-term results.
Fantastic program. Truly a life changer.
“FANTASTIC program! Truly a life changer! The first several months I lost on average 3 pounds a week. I have now lost 87 pounds in 10 months and I'm still losing! I can say it feels almost effortless, for with the elimination of most carbs plus the medication I have ZERO cravings and minimal hunger. My cholesterol, blood pressure, and blood sugar have all returned to normal having previously been considerably elevated. I look and feel twenty years younger (I am 57.) Staff is friendly and supportive, and the science works. I did not think that I would be able to achieve such results, and certainly not in less than a year. I am amazed at my success, and I could not have done it without Dr. Tumpati and W8MD.”
- D.M., actual W8MD patient who lost 100 lbs and has maintained the weight loss for over 10 years. Individual results vary.
W8MD locations
| Location | Address | Phone | Services | Map |
|---|---|---|---|---|
| Brooklyn / New York City Weight Loss and MedSpa Center | 2632 E 21st Street, Suite L3, Brooklyn, NY 11235 | (718) 946-5500 | Postpartum medical weight loss, insulin resistance care, prediabetes prevention, PCOS weight management, GLP-1 weight loss injections when appropriate, nutrition counseling, exercise counseling, sleep medicine, MedSpa | View map |
| Philadelphia / Greater Philadelphia Weight Loss and MedSpa Center | 1718 Welsh Road, 2nd Floor, Suite C, Philadelphia, PA 19115 | (215) 676-2334 | Postpartum medical weight loss, insulin resistance care, prediabetes prevention, PCOS weight management, GLP-1 weight loss injections when appropriate, nutrition counseling, exercise counseling, sleep medicine, wellness services | View map |
When to seek medical help
Pregnant patients should seek urgent or prompt medical care through their obstetric or pregnancy care team for:
- Very high blood glucose readings
- Decreased fetal movement
- Severe abdominal pain
- Severe headache
- Vision changes
- Swelling with high blood pressure
- Persistent vomiting
- Signs of dehydration
- Symptoms of preeclampsia
- Concern about insulin or medication dosing
Nonpregnant or postpartum patients should seek metabolic evaluation if they have:
- History of gestational diabetes
- Postpartum weight retention
- Prediabetes
- PCOS
- Abdominal weight gain
- Strong sugar or starch cravings
- High triglycerides
- Low HDL cholesterol
- Fatty liver disease
- Hypertension
- Snoring or sleep apnea symptoms
- Family history of type 2 diabetes
Frequently asked questions
What is gestational diabetes?
Gestational diabetes is diabetes first recognized during pregnancy. It occurs when pregnancy-related insulin resistance exceeds the body's ability to produce enough insulin.
Is insulin resistance the underlying issue in gestational diabetes?
Yes. Gestational diabetes is fundamentally a condition of pregnancy-related insulin resistance with inadequate insulin compensation.
Why does pregnancy cause insulin resistance?
Placental hormones and pregnancy-related metabolic changes make the mother's body less sensitive to insulin, especially in the second and third trimesters.
Is pregnancy a stress test for insulin resistance?
Yes. Pregnancy can reveal underlying subclinical insulin resistance. Patients who already have insulin resistance before pregnancy are more likely to develop gestational diabetes.
Does gestational diabetes go away after delivery?
It often improves after delivery because placental hormone effects decrease. However, future risk of prediabetes and type 2 diabetes remains elevated.
How is gestational diabetes diagnosed?
It is diagnosed with glucose screening and oral glucose tolerance testing, most often between 24 and 28 weeks of pregnancy, though high-risk patients may need earlier screening.
How is gestational diabetes treated?
Treatment includes medical nutrition therapy, blood glucose monitoring, physical activity when approved, and medication such as insulin when needed.
Can GLP-1 medications treat gestational diabetes during pregnancy?
No. GLP-1 medications such as Semaglutide and Tirzepatide are not used to treat gestational diabetes during pregnancy.
Can W8MD help with gestational diabetes?
W8MD can help before pregnancy, between pregnancies, and after pregnancy with insulin resistance, postpartum weight management, PCOS-related weight gain, prediabetes prevention, sleep apnea evaluation, and long-term medical weight management. Active gestational diabetes during pregnancy should be managed by obstetrics, maternal-fetal medicine, endocrinology, or diabetes specialists.
Can W8MD help reduce future diabetes risk after gestational diabetes?
Yes. W8MD can help with weight management, low-glycemic nutrition, physical activity planning, sleep apnea care, and medications when appropriate after pregnancy and breastfeeding.
Conclusion
Gestational diabetes is diabetes first recognized during pregnancy and is best understood as a condition of pregnancy-related insulin resistance combined with limited pancreatic insulin compensation. Pregnancy acts as a metabolic stress test: patients with underlying subclinical insulin resistance may develop gestational diabetes when placental hormones increase insulin demand. Although gestational diabetes often improves after delivery, it is a major warning sign for future insulin resistance, prediabetes, type 2 diabetes, metabolic syndrome, and postpartum weight challenges. Active gestational diabetes should be managed by obstetric and diabetes specialists. W8MD Weight Loss, Sleep and MedSpa, with over 16 years of physician experience, can help patients before pregnancy, between pregnancies, and after pregnancy through evidence-based medical weight management, low-glycemic nutrition, culturally customized diet plans, sleep apnea evaluation, postpartum weight management, GLP-1 medications when appropriate after pregnancy and breastfeeding, and long-term diabetes prevention.
See also
- Gestational diabetes
- Insulin resistance
- Prediabetes
- Type 2 diabetes
- Metabolic syndrome
- PCOS
- Obesity
- Overweight
- Weight gain
- Postpartum weight retention
- Medical weight loss
- Low-glycemic diet
- Low-carbohydrate diet
- W8MD weight loss diet
- GLP-1 weight loss injections
- Semaglutide
- Tirzepatide
- Metformin
- Sleep apnea
- W8MD Weight Loss, Sleep and MedSpa
Relevant WikiMD links
- Gestational diabetes on WikiMD
- Insulin resistance on WikiMD
- Prediabetes on WikiMD
- Type 2 diabetes on WikiMD
- Metabolic syndrome on WikiMD
- PCOS on WikiMD
- Medical weight loss on WikiMD
- Low-glycemic diet on WikiMD
- Low-carbohydrate diet on WikiMD
- W8MD weight loss diet on WikiMD
- GLP-1 weight loss injections on WikiMD
- Semaglutide on WikiMD
- Tirzepatide on WikiMD
- Sleep apnea on WikiMD
Further reading
- Gestational Diabetes(link). Centers for Disease Control and Prevention.May 15, 2024.
- Diabetes During Pregnancy(link). Centers for Disease Control and Prevention.May 15, 2024.
- Symptoms & Causes of Gestational Diabetes(link). National Institute of Diabetes and Digestive and Kidney Diseases.
- "15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2026".Diabetes Care.2026;49(Supplement_1)
- S321-S335.doi:10.2337/dc26-S015.
- "2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2026".Diabetes Care.2026;49(Supplement_1)
- S27-S45.doi:10.2337/dc26-S002.
- "ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus".Obstetrics & Gynecology.2018;PMID:29370047.
- "Insulin resistance, metabolic syndrome and polycystic ovaries".Frontiers in Endocrinology.2025;PMC:12520869.
- "Effect of low glycaemic index or load dietary patterns on glycaemic control and cardiometabolic risk factors in diabetes: systematic review and meta-analysis of randomised controlled trials".BMJ.2021;374
- Adult Activity: An Overview(link). Centers for Disease Control and Prevention.December 20, 2023.
- Prevent Type 2 Diabetes: Talking to Your Patients About Lifestyle Change(link). Centers for Disease Control and Prevention.May 15, 2024.
External links
- Gestational diabetes on WikiMD
- Insulin resistance on WikiMD
- Prediabetes on WikiMD
- Type 2 diabetes on WikiMD
- Metabolic syndrome on WikiMD
- PCOS on WikiMD
- Medical weight loss on WikiMD
- W8MD weight loss diet
- W8MD Weight Loss, Sleep and MedSpa Centers
- NYC medical weight loss
- Philadelphia medical weight loss
| W8MD Weight Loss, Sleep and MedSpa | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
| GLP-1 receptor agonists, incretin therapy, and weight loss medications | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
